SIGA Technologies Inc
NASDAQ:SIGA

Watchlist Manager
SIGA Technologies Inc Logo
SIGA Technologies Inc
NASDAQ:SIGA
Watchlist
Price: 5.91 USD -1.99% Market Closed
Market Cap: 421.8m USD
Have any thoughts about
SIGA Technologies Inc?
Write Note

SIGA Technologies Inc
Other Non-Cash Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SIGA Technologies Inc
Other Non-Cash Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Non-Cash Items CAGR 3Y CAGR 5Y CAGR 10Y
SIGA Technologies Inc
NASDAQ:SIGA
Other Non-Cash Items
$3.7m
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
16%
Johnson & Johnson
NYSE:JNJ
Other Non-Cash Items
$3.5B
CAGR 3-Years
37%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Other Non-Cash Items
$14.3B
CAGR 3-Years
6%
CAGR 5-Years
90%
CAGR 10-Years
80%
Pfizer Inc
NYSE:PFE
Other Non-Cash Items
$6.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
35%
Merck & Co Inc
NYSE:MRK
Other Non-Cash Items
$5.1B
CAGR 3-Years
-12%
CAGR 5-Years
12%
CAGR 10-Years
27%
Eli Lilly and Co
NYSE:LLY
Other Non-Cash Items
$4.5B
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
26%
No Stocks Found

SIGA Technologies Inc
Glance View

Market Cap
421.8m USD
Industry
Pharmaceuticals

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company is headquartered in New York City, New York and currently employs 39 full-time employees. The Company’s lead product, TPOXX (oral TPOXX), is an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The firm does not have a manufacturing infrastructure and does not intend to develop one for the manufacture of TPOXX. The company uses contract manufacturing organizations (CMOs) to procure commercial raw materials and supplies, and to manufacture TPOXX. The Company’s CMOs apply methods and controls in facilities, which are uses for manufacturing, processing, packaging, testing, analyzing and holding pharmaceuticals, which conform to current good manufacturing practices (cGMP), the standard set by the FDA for manufacture and storage of pharmaceuticals intended for human use. For the manufacture of oral TPOXX, the Company uses the four CMOs, namely W.R. Grace and Company; Powdersize, LLC; Catalent Pharma Solutions LLC, and Packaging Coordinators, LLC.

SIGA Intrinsic Value
13.95 USD
Undervaluation 58%
Intrinsic Value
Price

See Also

What is SIGA Technologies Inc's Other Non-Cash Items?
Other Non-Cash Items
3.7m USD

Based on the financial report for Sep 30, 2024, SIGA Technologies Inc's Other Non-Cash Items amounts to 3.7m USD.

What is SIGA Technologies Inc's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 10Y
16%

Over the last year, the Other Non-Cash Items growth was 28%. The average annual Other Non-Cash Items growth rates for SIGA Technologies Inc have been 18% over the past three years , and 16% over the past ten years .

Back to Top